Introduction With the recent FDA approvals of pegcetacoplan (SYFOVRE, Apellis
Pharmaceuticals) and avacincaptad pegol (IZERVAY, Astellas Pharmaceuticals) …

Purpose: To investigate the prevalence of geographic atrophy (GA) in advanced age-related
macular degeneration (AMD) and the proportion of eyes that would meet the indication …

PCME generally occurs around 6 weeks postoperatively and is likely a consequence of
postoperative inflammation with disruption of the blood-queous and blood-retina barriers …

Purpose: To assess the impact of switching to, or adding, an intravitreal dexamethasone
implant (Dex; Ozurdex®) in anti-vascular endothelial growth factor (VEGF) therapy on …

Purpose To examine the prevalence and distribution of fluid within a cohort of eyes with
acute central retinal artery occlusion (CRAO) and non-arteritic anterior ischemic optic …

Purpose: Fluid presence and dynamism is central to the diagnosis and management of
neovascular age-related macular degeneration. On optical coherence tomography (OCT) …

Age-related macular degeneration (AMD) is a leading cause of blindness worldwide. In late-
stage AMD, geographic atrophy (GA) of dry AMD or choroidal neovascularization (CNV) of …

Purpose To identify baseline OCT predictors of the 3-year macular atrophy (MA)
development for type 3 (T3) macular neovascularization (MNV) secondary to neovascular …

The abnormal growth of irregular new blood vessels into the subretinal or intraretinal space
is known as macular neovascularization (MNV). People over 50 are often affected by this …

Background: Pachychoroid neovasculopathy (PNV) is a pachychoroid-spectrum disease. As
blood circulation throughout the choroid may be involved in PNV pathogenesis, analysis …